Bio-Techne Corporation
TECH
Classificação em ações
#1871
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures,... Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Preço da ação
$72.55
Última sincronização: 2026-10-16
Valor de mercado
$11.38B
Variação (1 dia)
0.03%
Variação (1 ano)
17.27%
País
US
Negociar Bio-Techne Corporation (TECH)
Categoria
Healthcare
Lucros da Bio-Techne Corporation (TECH)
Lucros em Jun 2026 TTM: $240.68M
De acordo com os últimos relatórios financeiros da Bio-Techne Corporation, os ganhos atuais da empresa são de $240.68M. Em 2024, a empresa teve ganhos de $185.69M, uma diminuição em relação a aos ganhos de 2023, que foram de $338.66M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Bio-Techne Corporation de 2000 a 2026
Lucros no final de cada ano
| Ano | Lucros | Alterar |
|---|---|---|
| 2026 (TTM) | $240.68M | 144.44% |
| 2025 | $98.46M | -46.97% |
| 2024 | $185.69M | -45.17% |
| 2023 | $338.66M | 12.37% |
| 2022 | $301.39M | 103.40% |
| 2021 | $148.18M | -46.41% |
| 2020 | $276.48M | 146.82% |
| 2019 | $112.02M | -11.07% |
| 2018 | $125.95M | 11.30% |
| 2017 | $113.16M | -23.27% |
| 2016 | $147.48M | -4.33% |
| 2015 | $154.16M | -4.48% |
| 2014 | $161.39M | 0.45% |
| 2013 | $160.66M | -0.95% |
| 2012 | $162.20M | -1.69% |
| 2011 | $164.98M | 5.46% |
| 2010 | $156.45M | 0.70% |
| 2009 | $155.36M | 1.00% |
| 2008 | $153.83M | 19.31% |
| 2007 | $128.93M | 15.98% |
| 2006 | $111.16M | 11.29% |
| 2005 | $99.89M | 21.02% |
| 2004 | $82.54M | 18.67% |
| 2003 | $69.56M | 84.32% |
| 2002 | $37.74M | -21.07% |
| 2001 | $47.81M | 21.30% |
| 2000 | $39.41M | 0.00% |
Lucros de empresas semelhantes ou concorrentes
| Empresa | Lucros | Diferença de Lucros | País |
|---|---|---|---|
| $5.27B | 2,091.67% |
US
|
|
| $-3.09B | -1,382.62% |
US
|
|
| $-4.02B | -1,768.69% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | 710.47% |
NL
|
